Detalhe da pesquisa
1.
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
N Engl J Med
; 380(3): 229-241, 2019 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30650326
2.
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
N Engl J Med
; 380(3): 215-228, 2019 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30650322
3.
Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria.
Pharmacogenet Genomics
; 30(7): 161-165, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32433338
4.
A randomized, double-blind, comparative study to assess the safety and efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of secondarily infected traumatic lesions and impetigo due to methicillin-resistant Staphylococcus aureus.
Adv Skin Wound Care
; 27(12): 548-59, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25396674
5.
The safety and efficacy of topical retapamulin ointment versus placebo ointment in the treatment of secondarily infected traumatic lesions: a randomized, double-blind superiority study.
Adv Skin Wound Care
; 26(3): 113-21, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23426412
6.
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.
Lancet Child Adolesc Health
; 6(2): 86-95, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871570